Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margie D Dixon

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer|July 27, 2017
Cancer donor preferences for disposition of their biospecimens after biobank closureSamuel C Allen, Margie D Dixon, Jeffrey M Switchenko, et al.
Clinical Trials (London, England)|August 31, 2015
Description of the types and content of phase 1 clinical trial consent conversations in practiceLouisa Wall, Zachary Luke Farmer, Margaret White Webb, et al.
Cancer|July 13, 2016
Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participationAjay K Nooka, Madhusmita Behera, Sagar Lonial, et al.
Psycho-Oncology|May 26, 2021
Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trialsRachel S Hianik, Taofeek Owonikoko, Jeffrey Switchenko, et al.
Cancer Medicine|February 2, 2022
Dissemination of validated health literacy videos: A tailored approachShannon M Blee, Jamil Facdol, Margie D Dixon, et al.
Therapeutic Advances in Medical Oncology|January 24, 2019
Academic oncology clinicians' understanding of biosimilars and information needed before prescribingJohn W Cook, Megan K McGrath, Margie D Dixon, et al.
The Oncologist|October 23, 2025
Exploring the ethical use of race in cancer researchKersten J Pierre, Catherine Diop Chalmers, Chineme Amechi, et al.
AJOB Empirical Bioethics|April 4, 2018
Patient perspectives on compensation for biospecimen donationSamuel C Allen, Minisha Lohani, Kristopher A Hendershot, et al.
The Oncologist|February 22, 2017
Using Metaphors to Explain Molecular Testing to Cancer PatientsAna P M Pinheiro, Rachel H Pocock, Margie D Dixon, et al.
Cancer|February 1, 2017
Discussing molecular testing in oncology care: Comparing patient and physician information preferencesAna P M Pinheiro, Rachel H Pocock, Jeffrey M Switchenko, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer|July 27, 2017
Cancer donor preferences for disposition of their biospecimens after biobank closureSamuel C Allen, Margie D Dixon, Jeffrey M Switchenko, et al.
Clinical Trials (London, England)|August 31, 2015
Description of the types and content of phase 1 clinical trial consent conversations in practiceLouisa Wall, Zachary Luke Farmer, Margaret White Webb, et al.
Cancer|July 13, 2016
Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participationAjay K Nooka, Madhusmita Behera, Sagar Lonial, et al.
Psycho-Oncology|May 26, 2021
Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trialsRachel S Hianik, Taofeek Owonikoko, Jeffrey Switchenko, et al.
Cancer Medicine|February 2, 2022
Dissemination of validated health literacy videos: A tailored approachShannon M Blee, Jamil Facdol, Margie D Dixon, et al.
Therapeutic Advances in Medical Oncology|January 24, 2019
Academic oncology clinicians' understanding of biosimilars and information needed before prescribingJohn W Cook, Megan K McGrath, Margie D Dixon, et al.
The Oncologist|October 23, 2025
Exploring the ethical use of race in cancer researchKersten J Pierre, Catherine Diop Chalmers, Chineme Amechi, et al.
AJOB Empirical Bioethics|April 4, 2018
Patient perspectives on compensation for biospecimen donationSamuel C Allen, Minisha Lohani, Kristopher A Hendershot, et al.
The Oncologist|February 22, 2017
Using Metaphors to Explain Molecular Testing to Cancer PatientsAna P M Pinheiro, Rachel H Pocock, Margie D Dixon, et al.
Cancer|February 1, 2017
Discussing molecular testing in oncology care: Comparing patient and physician information preferencesAna P M Pinheiro, Rachel H Pocock, Jeffrey M Switchenko, et al.
Pageof 3